Revatio Injury Alert: Potential Revatio Lawsuits Being Investigated By Bernstein Liebhard LLP

Share Article

Revatio lawsuit claims brought on behalf of individuals who allegedly sustained Revatio injuries, such as heart failure and/or death are currently being evaluated by Bernstein Liebhard LLP.

Bernstein Liebhard LLP | Consumer Injury Lawyers
Children taking a high dose of Revatio had a higher risk of death than children taking a low dose.

Potential Revatio lawsuits are currently being evaluated by Bernstein Liebhard LLP, a New York law firm nationally recognized for its consumer protection and mass tort practices, on behalf of individuals alleging that they suffered a Revatio injury. Manufactured by Pfizer, Revatio received approval from the U.S. Food and Drug Administration (“FDA”) in 2005 to treat pulmonary arterial hypertension (“PAH”) in adults. However, it is often prescribed off-label to treat children also suffering from PAH. On August 30, 2012, the FDA issued a drug safety communication recommending that Revatio not be prescribed to children between the ages of 1 and 17, after results from a long-term clinical pediatric trial revealed that children taking a high dose of Revatio for the treatment of PAH faced an unexpectedly high rate of mortality.* Specifically, the clinical trial found that:

  •     Children taking a high dose of Revatio had a higher risk of death than children taking a low dose; and
  •     Low doses of Revatio are not effective in improving exercise ability.

Given the severity and dangers associated with Revatio injuries, the lawyers at Bernstein Liebhard LLP are currently offering free and confidential case evaluations to individuals whose children suffered serious injuries, including heart failure and/or death while being treated with Revatio.

In addition to changing the drug’s labeling to include information warning doctors against using Revatio to treat children, the FDA is also requiring Pfizer to evaluate Revatio’s effect on the risk of death in adults with PAH. Currently, the effect of Revatio on the risk of death with long-term use in adults is unknown.

Revatio Injuries In Children Can Cause Death

According to the FDA’s drug safety communication, most deaths of children participating in the study were caused by pulmonary hypertension and heart failure, which are the most common causes of death in children with PAH.

Those who suffered side effects, such as heart failure and/or death as a result of being treated with Revatio may be entitled to compensation for medical bills, pain and suffering, lost wages and other injuries. For more information about filing a Revatio lawsuit, visit http://www.consumerinjurylawyers.com/revatio-lawsuit/. You can also contact an attorney at Bernstein Liebhard LLP at (877) 779-1414.

*fda.gov/Drugs/DrugSafety/ucm317123.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers.com
http://www.consumerinjurylawyers.com
http://www.consumerinjurylawyers.com/revatio-lawsuit/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website